Suppr超能文献

砷剂中毒性周围血管病的间充质干细胞治疗。

Treatment of Arsenite Intoxication-Induced Peripheral Vasculopathy with Mesenchymal Stem Cells.

机构信息

Institute of Clinical Medicine, National Yang-Ming University, Taipei 11221, Taiwan.

Department of Orthopaedics, National Yang-Ming University Hospital, Yilan 260, Taiwan.

出版信息

Int J Mol Sci. 2018 Mar 29;19(4):1026. doi: 10.3390/ijms19041026.

Abstract

Arsenite (As), a notorious toxic metal, is ubiquitously distributed in the earth and poses a serious threat to human health. Histopathological lesions of As intoxication are known as thromboangiitis obliterans, which are resistant to current treatment and often lead to lower limb amputation. In this study, we attempt to find that treatment with mesenchymal stem cells (MSCs) may be effective for As-induced vasculopathy. We first conducted an in vitro study with a co-culture system containing human MSCs and human umbilical vein endothelial cells (HUVECs) and treated individual and co-cultured cells with various concentrations of arsenite. We also designed an in vivo study in which Sprague Dawley (SD) rats received periodic intraperitoneal (IP) injections of 16 ppm arsenite for 12 weeks. MSCs were harvested from BALB/c mice that were transplanted via tail vein injection. We found that there was significantly higher cellular viability in human mesenchymal stem cells (hMSCs) than in HUVECs under concentrations of arsenite between 15 and 25 μM. The Annexin V apoptosis assay further confirmed this finding. Cytokine array assay for As-conditioned media revealed an elevated vascular endothelial growth factor (VEGF) level secreted by MSCs, which is crucial for HUVEC survival and was evaluated by an siRNA VEGF knockdown test. In the in vivo study, we demonstrated early apoptotic changes in the anterior tibial vessels of As-injected SD rats with a Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay, but these apoptotic changes were less frequently observed upon MSCs transplantation, indicating that the cytoprotective effect of MSCs successfully protected against As-induced peripheral vasculopathy. The feasibility of MSCs to treat and /or prevent the progression of As-induced vasculopathy is justified. Further clinical studies are required to demonstrate the therapeutic efficacy of MSCs in patients suffering from As intoxication with vasculopathy.

摘要

砷(As)是一种臭名昭著的有毒金属,广泛分布于地球中,对人类健康构成严重威胁。砷中毒的组织病理学病变被称为血栓闭塞性脉管炎,这种疾病对现有治疗方法具有抗性,并且常常导致下肢截肢。在这项研究中,我们试图发现间充质干细胞(MSCs)的治疗可能对砷诱导的血管病变有效。我们首先进行了一项体外研究,该研究使用包含人骨髓间充质干细胞(hMSCs)和人脐静脉内皮细胞(HUVEC)的共培养系统,并使用不同浓度的砷处理单个细胞和共培养细胞。我们还设计了一项体内研究,其中 Sprague Dawley(SD)大鼠接受周期性腹腔(IP)注射 16 ppm 砷 12 周。MSCs 是从通过尾静脉注射移植的 BALB/c 小鼠中收获的。我们发现,在浓度为 15 至 25 μM 的砷化物下,hMSCs 的细胞活力明显高于 HUVEC。Annexin V 凋亡检测进一步证实了这一发现。对砷处理的条件培养基进行细胞因子阵列分析显示,MSC 分泌的血管内皮生长因子(VEGF)水平升高,这对于 HUVEC 的存活至关重要,并通过 siRNA VEGF 敲低试验进行了评估。在体内研究中,我们通过末端脱氧核苷酸转移酶 dUTP 缺口末端标记(TUNEL)试验证明了注射砷的 SD 大鼠前胫骨血管中的早期凋亡变化,但在 MSC 移植后观察到这些凋亡变化较少,这表明 MSC 的细胞保护作用成功地防止了砷诱导的周围血管病。MSCs 治疗和/或预防砷诱导的血管病进展的可行性是合理的。需要进一步的临床研究来证明 MSCs 在患有血管病的砷中毒患者中的治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e692/5979449/092f9e799685/ijms-19-01026-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验